- Home
- GBR vs BMRA Comparison
GBR vs BMRA Comparison
Compare GBR & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBR
- BMRA
- Stock Information
- Founded
- GBR 1978
- BMRA 1971
- Country
- GBR United States
- BMRA United States
- Employees
- GBR N/A
- BMRA N/A
- Industry
- GBR Oil & Gas Production
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GBR Energy
- BMRA Health Care
- Exchange
- GBR Nasdaq
- BMRA Nasdaq
- Market Cap
- GBR 7.0M
- BMRA 8.1M
- IPO Year
- GBR N/A
- BMRA N/A
- Fundamental
- Price
- GBR $1.06
- BMRA $3.09
- Analyst Decision
- GBR
- BMRA
- Analyst Count
- GBR 0
- BMRA 0
- Target Price
- GBR N/A
- BMRA N/A
- AVG Volume (30 Days)
- GBR 256.6K
- BMRA 26.1K
- Earning Date
- GBR 08-12-2025
- BMRA 04-14-2025
- Dividend Yield
- GBR N/A
- BMRA N/A
- EPS Growth
- GBR N/A
- BMRA N/A
- EPS
- GBR N/A
- BMRA N/A
- Revenue
- GBR $148,000.00
- BMRA $5,678,000.00
- Revenue This Year
- GBR N/A
- BMRA N/A
- Revenue Next Year
- GBR N/A
- BMRA N/A
- P/E Ratio
- GBR N/A
- BMRA N/A
- Revenue Growth
- GBR 3.50
- BMRA 5.01
- 52 Week Low
- GBR $0.67
- BMRA $1.93
- 52 Week High
- GBR $1.82
- BMRA $10.16
- Technical
- Relative Strength Index (RSI)
- GBR 50.08
- BMRA 45.39
- Support Level
- GBR $0.84
- BMRA $3.03
- Resistance Level
- GBR $1.60
- BMRA $3.44
- Average True Range (ATR)
- GBR 0.20
- BMRA 0.19
- MACD
- GBR -0.01
- BMRA 0.01
- Stochastic Oscillator
- GBR 21.59
- BMRA 43.24
About GBR New Concept Energy Inc
New Concept Energy Inc is a United States-based company engaged in Real Estate Operations. It intends to continue to operate and or sell its West Virginia property. It provides advisory and management services for an independent West Virginia oil and gas company. The Company seeks to establish or acquire new business operations. It operates in one segment, which is real estate rental.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.